Thermo Fisher Scientific (TMO) Receivables - Net (2016 - 2025)
Thermo Fisher Scientific (TMO) has disclosed Receivables - Net for 16 consecutive years, with $8.3 billion as the latest value for Q3 2024.
- For the quarter ending Q3 2024, Receivables - Net fell 1.37% year-over-year to $8.3 billion, compared with a TTM value of $8.3 billion through Sep 2024, down 1.37%, and an annual FY2023 reading of $8.2 billion, up 1.31% over the prior year.
- Receivables - Net was $8.3 billion for Q3 2024 at Thermo Fisher Scientific, up from $7.9 billion in the prior quarter.
- Across five years, Receivables - Net topped out at $8.4 billion in Q3 2023 and bottomed at $4.5 billion in Q2 2020.
- Average Receivables - Net over 5 years is $7.0 billion, with a median of $7.9 billion recorded in 2022.
- The sharpest move saw Receivables - Net surged 42.04% in 2022, then decreased 1.37% in 2024.
- Year by year, Receivables - Net stood at $5.7 billion in 2020, then surged by 38.95% to $8.0 billion in 2021, then increased by 1.73% to $8.1 billion in 2022, then increased by 1.31% to $8.2 billion in 2023, then increased by 0.41% to $8.3 billion in 2024.
- Business Quant data shows Receivables - Net for TMO at $8.3 billion in Q3 2024, $7.9 billion in Q2 2024, and $7.9 billion in Q1 2024.